Home/Filings/4/0001415889-24-006070
4//SEC Filing

Busse Falko 4

Accession 0001415889-24-006070

CIK 0001109354other

Filed

Feb 29, 7:00 PM ET

Accepted

Mar 1, 4:05 PM ET

Size

24.6 KB

Accession

0001415889-24-006070

Insider Transaction Report

Form 4
Period: 2024-02-28
Busse Falko
PRESIDENT, BIOSPIN GROUP
Transactions
  • Exercise/Conversion

    Stock Option (Right to Purchase)

    2024-02-284,3840 total
    Exercise: $34.02Exp: 2028-08-09Common Stock (4,384 underlying)
  • Exercise/Conversion

    Common Stock

    2024-02-28$19.82/sh+12,000$237,84044,859 total
  • Exercise/Conversion

    Common Stock

    2024-02-28$22.19/sh+7,097$157,48251,956 total
  • Exercise/Conversion

    Common Stock

    2024-02-28$34.02/sh+4,384$149,14456,340 total
  • Exercise/Conversion

    Common Stock

    2024-02-28$41.95/sh+4,641$194,69060,981 total
  • Sale

    Common Stock

    2024-02-28$86.06/sh13,852$1,192,10347,129 total
  • Sale

    Common Stock

    2024-02-28$84.97/sh12,770$1,085,06734,359 total
  • Sale

    Common Stock

    2024-02-28$84.48/sh1,500$126,72032,859 total
  • Exercise/Conversion

    Stock Option (Right to Purchase)

    2024-02-2812,0000 total
    Exercise: $19.82Exp: 2025-08-07Common Stock (12,000 underlying)
  • Exercise/Conversion

    Stock Option (Right to Purchase)

    2024-02-287,0970 total
    Exercise: $22.19Exp: 2026-10-04Common Stock (7,097 underlying)
  • Exercise/Conversion

    Stock Option (Right to Purchase)

    2024-02-284,6410 total
    Exercise: $41.95Exp: 2029-08-08Common Stock (4,641 underlying)
Footnotes (7)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.52 to $86.50, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.52 to $85.50, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.46 to $84.50, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The stock option granted to the Reporting Person on August 7, 2015 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
  • [F5]The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
  • [F6]The stock option granted to the Reporting Person on August 9, 2018 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
  • [F7]The stock option granted to the Reporting Person on August 8, 2019 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.

Issuer

BRUKER CORP

CIK 0001109354

Entity typeother

Related Parties

1
  • filerCIK 0001739999

Filing Metadata

Form type
4
Filed
Feb 29, 7:00 PM ET
Accepted
Mar 1, 4:05 PM ET
Size
24.6 KB